Circle Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Circle Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,755	Closed	-$335K	–	199
2023 Q4	$335K	Hold	3,755	–	–	0.01%	162
2023 Q3	$274K	Hold	3,755	–	–	0.01%	176
2023 Q2	$312K	Hold	3,755	–	–	0.04%	136
2023 Q1	$286K	Buy	+3,755	New	+$312K	0.04%	139
2022 Q2	–	Sell	-7,191	Closed	-$646K	–	182
2022 Q1	$646K	Sell	7,191 -5,796	-45%	-$535K	0.08%	102
2021 Q4	$1.45M	Buy	12,987 +1,196	+10%	+$144K	0.19%	51
2021 Q3	$1.48M	Buy	11,791 +179	+2%	+$23.1K	0.21%	50
2021 Q2	$1.57M	Buy	+11,612	New	+$1.53M	0.23%	50

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Circle Wealth Management's XBI Position: Q1 2024 in Review

Circle Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 3,755 shares — an estimated $335K sold.

Circle Wealth Management first reported a position in XBI in Q2 2021 and held it in 8 quarters. The position peaked at $1.57M in Q2 2021. 781 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Circle Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
Circle Wealth Management sold 3,755 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $335K.
Circle Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 8 quarters.
Circle Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $1.57M in Q2 2021.
781 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Circle Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.